Increased expression of IGFBP3 in RCC (and also in lung and colorectal cancer) was associated with inferior overall survival, while IGFBP5 expression had no apparent impact on prognosis in RCC (Supplementary Fig. 4F, G). Here, IGFBP5 is linked to colorectal cancer.